Montavon
Christophe Andre Joseph Montavon, Ixelles BE
Patent application number | Description | Published |
---|---|---|
20150238746 | FRANGIBLE CONNECTOR CLOSURE FOR TUBULAR CONNECTOR - A frangible connector closure is provided for connection to a medication administration tube, and includes a tubular body portion having an open end configured for being connected to a supply of medication, and an opposite closed end. An elongate, rigid frangible member is disposed at the closed end and closes the end from fluid flow. The frangible member has a closure end and an opposite free end, and a longitudinal axis. In addition, the frangible member extends in an axial direction and has a member transverse dimension. The free end forms a finger portion extending in the axial direction and has a transverse dimension less than the member transverse dimension. The closure end of the frangible member is readily separable from the body portion by manual manipulation relative to the body portion when the frangible member is disposed inside the tube, for user-activated opening of the connector. | 08-27-2015 |
Jean-Charles Montavon, Lausanne CH
Patent application number | Description | Published |
---|---|---|
20110152608 | FLOW CONTROL METHOD AND DEVICE - Apparatus and methods are provided comprising an implantable non-hydraulic ring that encircles and provides a controllable degree of constriction to an organ or duct and an external control that powers and controls operation of the ring. The ring includes a rigid dorsal periphery that maintains a constant exterior diameter, and a compliant constriction system that reduces intolerance phenomena. A high precision, energy efficient mechanical actuator is employed that is telemetrically powered and controlled, and maintains the ring at a selected diameter when the device is unpowered, even for extended periods. The actuator provides a reversible degree of constriction of the organ or duct, which is readily ascertainable without the need for radiographic imaging. Methods of use and implantation also are provided. | 06-23-2011 |
20110270025 | REMOTELY POWERED REMOTELY ADJUSTABLE GASTRIC BAND SYSTEM - A remotely adjustable remotely power gastric band system may include a control device, an implant electronic device, and an implantable gastric band. The control device may telemetrically power and communicate with the implant electronic device, which may be used for adjusting the diameter of the implantable gastric band. The implant electronic device may store the gastric band adjustment history records of a patient and regulate the power received from the control device. To improve transmission efficiency, the implant electronic device may adopt a double modulation scheme for communicating with the control device. Furthermore, the implant electronic device may detect and resolve motor blockage issues related to the implantable gastric band. | 11-03-2011 |
20140039250 | FLOW CONTROL METHOD AND DEVICE - Apparatus and methods are provided comprising an implantable non-hydraulic ring that encircles and provides a controllable degree of constriction to an organ or duct and an external control that powers and controls operation of the ring. The ring includes a rigid dorsal periphery that maintains a constant exterior diameter, and a compliant constriction system that reduces intolerance phenomena. A high precision, energy efficient mechanical actuator is employed that is telemetrically powered and controlled, and maintains the ring at a selected diameter when the device is unpowered, even for extended periods. The actuator provides a reversible degree of constriction of the organ or duct, which is readily ascertainable without the need for radiographic imaging. Methods of use and implantation also are provided. | 02-06-2014 |
20140073848 | REMOTELY POWERED REMOTELY ADJUSTABLE GASTRIC BAND SYSTEM - A remotely adjustable remotely power gastric band system may include a control device, an implant electronic device, and an implantable gastric band. The control device may telemetrically power and communicate with the implant electronic device, which may be used for adjusting the diameter of the implantable gastric band. The implant electronic device may store the gastric band adjustment history records of a patient and regulate the power received from the control device. To improve transmission efficiency, the implant electronic device may adopt a double modulation scheme for communicating with the control device. Furthermore, the implant electronic device may detect and resolve motor blockage issues related to the implantable gastric band. | 03-13-2014 |
Lorraine Montavon, Zürich CH
Patent application number | Description | Published |
---|---|---|
20150305779 | SPRING AND DEVICE FOR STABILIZING HUMAN OR ANIMAL BONE - Disclosed is a spring for a device for stabilizing bones. The spring is designed as a leg spring that includes a spring coil with at least one turn and, at the end, a first and a second leg, which project beyond the periphery of the turn. At its end, at least one leg includes a rod-shaped end piece that has a three-dimensional structure in the form of a turn or a peripheral leaf or lip. Also disclosed is a device for stabilizing bones, which includes a spring, a bone plate that includes means for securing the bone plate to the three-dimensional structure in the form of a turn or a peripheral leaf or lip, and a clamping element that has at least one hole for accepting a bone fixation element as well as a channel through which one of the two legs of the spring can be guided. | 10-29-2015 |
Philippe Montavon, Echichens CH
Patent application number | Description | Published |
---|---|---|
20110130472 | PROTEOSE PEPTONE FRACTION - The present invention generally relates to compositions comprising the proteose peptone fraction (PPf). In particular, the present invention relates to a method for the production of an extract comprising a demineralised protein fraction depleted in β-lactoglobulin and enriched in the PPf and to uses of these extracts, e.g. in a food product, a food supplement, a nutritional, a pharmaceutical and/or a cosmetic composition, for example as emulsifier or as foaming agent. The PPf fraction of the present invention may be obtained by adjustment of the pH of an aqueous native protein dispersion to about 5.6 to 8.4, or to about 3.5 to 5.0, heating the aqueous native protein dispersion to about 70-95° C. for about 10 seconds to 60 minutes, removing at least a part of the formed solid large molecular weight aggregates with a diameter of at least 100 nm from the aqueous protein dispersion after heating and collecting the remaining liquid fraction of the dispersion. | 06-02-2011 |
Timothy Montavon, Palatine, IL US
Patent application number | Description | Published |
---|---|---|
20140275506 | ALKENYL GLYCOSIDES AND THEIR PREPARATION - An alkenyl glycoside is prepared by reacting a metathesis-derived unsaturated fatty alcohol containing 10 to 30 carbon atoms with either (1) a reducible monosaccharide or composition hydrolyzable to a reducible monosaccharide, or (2) a hydrocarbyl glycoside produced by reacting an alcohol containing up to 6 carbon atoms with a reducible monosaccharide or composition hydrolyzable to a reducible monosaccharide. Each of these reactions is performed in the presence of an acid catalyst and under conditions sufficient to form the alkenyl glycoside or hydrocarbyl glycoside. The preferred alkenyl glycosides are 9-decen-1-yl glycoside; 9-dodecen-1-yl glycoside; 9-tridecen-1-yl glycoside; 9-pentadecen-1-yl glycoside; 9-octadecen-yl glycoside; or 9-octadecen-1,18-diyl glycoside. | 09-18-2014 |
20140275580 | GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION - A method is disclosed for making an unsaturated glycitan ester by reacting intramolecular condensates of glycitols having four or more carbons with a metathesis-derived unsaturated fatty acid in the presence of an alkaline catalyst and under conditions sufficient to form the aforesaid unsaturated glycitan fatty ester. A composition is also disclosed comprising a compound of the following structure: | 09-18-2014 |
20150307469 | Glycitan Esters of Unsaturated Fatty Acids and Their Preparation - A method is disclosed for making an unsaturated glycitan ester by reacting intramolecular condensates of glycitols having four or more carbons with a metathesis-derived unsaturated fatty acid in the presence of an alkaline catalyst and under conditions sufficient to form the aforesaid unsaturated glycitan fatty ester. A composition is also disclosed comprising a compound of the following structure: | 10-29-2015 |
Vincent Montavon, Hopewell Junction, NY US
Patent application number | Description | Published |
---|---|---|
20130297365 | SYSTEM AND METHOD FOR COORDINATED SCHEDULING - A schedule-coordination system and method that analyzes schedules of a plurality of users and detects schedule overlaps between the users. A first user can be proactively alerted to a schedule overlap with a second user, depending upon registration records of the first and second users. The system and method can also optimize the coordination of a user's schedule by facilitating changes to the schedule. | 11-07-2013 |
Vincent Montavon, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20090222291 | SYSTEM AND METHOD FOR COORDINATED SCHEDULING - A schedule-coordination system and method that analyzes schedules of a plurality of users and detects schedule overlaps between the users. A first user can be proactively alerted to a schedule overlap with a second user, depending upon registration records of the first and second users. The system and method can also optimize the coordination of a user's schedule by facilitating changes to the schedule. | 09-03-2009 |